Is tumour vaccination a valid alternative to second line treatment in hormone refractory prostate cancer? A review of the evidence

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalUroOncology
Volume3
Publication statusPublished - 2003

Keywords

  • HORMONE REFRACTORY PROSTATE CANCER

Cite this